Alliance Research Group: Particle based cancer immunotherapy

01 July 2015 → 31 July 2024
Ghent University funding
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
Project description

  In view of the interdisciplinary nature of the above-defined lines of research is very various knowledge is required in order to bring the experimental work to a successful conclusion. Both research groups have entirely complementary expertise but share the same objectives. Thus the expertise of Gern situated mainly in materials science right while LMCT has a very extensive immunological knowledge and much experience in vivo. At Ghent University is much (pharmaceutical) expertise in ‘ advanced drug delivery, while the university is a leader in medical and clinical aspects of ‘ advanced Biotherapies / cell Therapy.